- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
On-the-spot blood tests for Ebola discovered
Reduces transfer risks to medical laboratories, associated with health workers
According to a research published recently in the Lancet Journal, a rapid diagnosis is now possible for the deadly virus Ebola. The conventional lab based tests done until now are not just time consuming, but also come attached with the risk of virus leakage in the blood sample being carried. This can lead to a situation of a high probability exposure to the virus, along with delays in detecting the virus. As a result, this on-the-spot detection is a sure step forward to curb the Ebola virus spread.
The study also states that the results achieved through this new method are as accurate as the conventional lab based system. According to a PTI report, this point-of-care Ebola Virus Disease (EVD) test is faster than and as sensitive as a conventional lab-based molecular method used for clinical testing during the recent outbreak in Sierra Leone, as a result of a patient trail conducted by the authroities.
As quoted by PTI in its news report,
106 suspected Ebola patients admitted to two treatment centres in Sierra Leone during February 2015 were tested by both RDT (performed on a fingerstick blood sample at the point-of-care) and by standard RT-PCR (performed on plasma in the laboratory).
Both RDT (on whole blood) and RT-PCR (on plasma) were also performed on 284 samples in the laboratory. The RDT detected all confirmed cases of EVD that were positive by RT-PCR in both point-of-care (28/105 patients) and laboratory testing (45/277 patients), with sensitivity of 100 per cent, and a specificity of 92%.
According to a research published recently in the Lancet Journal, a rapid diagnosis is now possible for the deadly virus Ebola. The conventional lab based tests done until now are not just time consuming, but also come attached with the risk of virus leakage in the blood sample being carried. This can lead to a situation of a high probability exposure to the virus, along with delays in detecting the virus. As a result, this on-the-spot detection is a sure step forward to curb the Ebola virus spread.
The study also states that the results achieved through this new method are as accurate as the conventional lab based system. According to a PTI report, this point-of-care Ebola Virus Disease (EVD) test is faster than and as sensitive as a conventional lab-based molecular method used for clinical testing during the recent outbreak in Sierra Leone, as a result of a patient trail conducted by the authroities.
As quoted by PTI in its news report,
106 suspected Ebola patients admitted to two treatment centres in Sierra Leone during February 2015 were tested by both RDT (performed on a fingerstick blood sample at the point-of-care) and by standard RT-PCR (performed on plasma in the laboratory).
Both RDT (on whole blood) and RT-PCR (on plasma) were also performed on 284 samples in the laboratory. The RDT detected all confirmed cases of EVD that were positive by RT-PCR in both point-of-care (28/105 patients) and laboratory testing (45/277 patients), with sensitivity of 100 per cent, and a specificity of 92%.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story